Posted on 02/09/24
Baltimore, MD - Feb. 9, 2024 - Michael J Elman, M.D. presented the results of the Clinical Utility of Home OCT Data in Management of Neovascular Age Related Macular Degeneration at the 47th annual meeting of the Macula Society in Palm Springs, California on February 9, 2024. Home OCT offers the hope of improving outcomes in the treatment of retinal diseases by allowing treating physicians to personalize treatment specific to that patient’s response.
Dr. Elman has been actively involved in developing Home OCT with Notal Vision based in Tel Aviv, Israel. Previously, Dr Elman was a Principal Investigator on the National Eye Institute supported HOME Trial that established the superior role of Notal’s Foresee Home Monitoring System in preserving vision in eyes at risk for neovascular AMD. Elman Retina’s Dr. Sid Schechet currently serves as Principal Investigator in the DRCR Retina Network’s AO clinical trial comparing Home OCT with standard of care in the treatment of neovascular AMD eyes.